Jaffetilchin Investment Partners LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 1,565 shares of the medical technology company’s stock, valued at approximately $217,000.

Several other large investors also recently made changes to their positions in SYK. Bollard Group LLC grew its stake in shares of Stryker Corporation by 0.4% in the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares during the last quarter. Assetmark Inc. grew its stake in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after purchasing an additional 4 shares during the last quarter. Blue Chip Partners Inc. grew its stake in shares of Stryker Corporation by 0.3% in the first quarter. Blue Chip Partners Inc. now owns 1,775 shares of the medical technology company’s stock worth $234,000 after purchasing an additional 6 shares during the last quarter. Guardian Life Insurance Co. of America grew its stake in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after purchasing an additional 9 shares during the last quarter. Finally, FineMark National Bank & Trust grew its stake in shares of Stryker Corporation by 0.4% in the second quarter. FineMark National Bank & Trust now owns 3,878 shares of the medical technology company’s stock worth $538,000 after purchasing an additional 15 shares during the last quarter. 74.18% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Stryker Corporation (SYK) opened at 143.03 on Thursday. The company has a market cap of $53.50 billion, a P/E ratio of 31.93 and a beta of 0.81. The company’s 50 day moving average is $143.90 and its 200 day moving average is $138.47. Stryker Corporation has a 12 month low of $106.48 and a 12 month high of $148.84.

Stryker Corporation (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The firm had revenue of $3.01 billion during the quarter, compared to analysts’ expectations of $2.98 billion. During the same quarter in the prior year, the company earned $1.39 EPS. The company’s revenue was up 6.1% compared to the same quarter last year. On average, equities research analysts predict that Stryker Corporation will post $6.46 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be given a dividend of $0.425 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a yield of 1.19%. Stryker Corporation’s payout ratio is 37.95%.

ILLEGAL ACTIVITY NOTICE: This piece was published by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was stolen and republished in violation of US & international copyright and trademark law. The original version of this piece can be read at https://www.dailypolitical.com/2017/09/14/jaffetilchin-investment-partners-llc-acquires-new-position-in-stryker-corporation-syk.html.

Several analysts recently issued reports on the company. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a research note on Thursday, August 17th. Cowen and Company reissued a “buy” rating and issued a $160.00 target price (up from $150.00) on shares of Stryker Corporation in a research note on Sunday, July 30th. Zacks Investment Research cut Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, August 23rd. Canaccord Genuity reissued a “buy” rating and issued a $155.00 target price (down from $158.00) on shares of Stryker Corporation in a research note on Thursday, August 24th. Finally, Oppenheimer Holdings, Inc. set a $148.00 target price on Stryker Corporation and gave the stock a “hold” rating in a research note on Friday, July 28th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $145.73.

In related news, insider Graham A. Mclean sold 1,124 shares of the stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the sale, the insider now owns 8,983 shares of the company’s stock, valued at $1,313,853.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Lonny J. Carpenter sold 5,000 shares of the stock in a transaction that occurred on Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the sale, the insider now directly owns 88,207 shares of the company’s stock, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. Insiders have sold 25,429 shares of company stock valued at $3,686,927 in the last three months. 7.40% of the stock is currently owned by corporate insiders.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.